|
|
|
Volumn 11, Issue 8 Suppl 8, 1997, Pages 46-49
|
|
Combination docetaxel/vinorelbine for metastatic breast cancer and non-small-cell lung cancer.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
DOCETAXEL;
DRUG DERIVATIVE;
NAVELBINE;
PACLITAXEL;
TAXOID;
VINBLASTINE;
BREAST TUMOR;
CHEMICALLY INDUCED DISORDER;
DRUG POTENTIATION;
FEMALE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
METASTASIS;
NEUROLOGIC DISEASE;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
REMISSION;
REVIEW;
SURVIVAL RATE;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CARCINOMA, NON-SMALL-CELL LUNG;
CISPLATIN;
CLINICAL TRIALS, PHASE I;
CLINICAL TRIALS, PHASE II;
DRUG SYNERGISM;
FEMALE;
HUMANS;
INFUSIONS, INTRAVENOUS;
LUNG NEOPLASMS;
NEOPLASM METASTASIS;
NERVOUS SYSTEM DISEASES;
PACLITAXEL;
REMISSION INDUCTION;
SURVIVAL RATE;
TAXOIDS;
VINBLASTINE;
|
|
EID: 0031204222
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (8)
|
|
References (15)
|
